Evidence suggests that the enterotoxigenic Bacteroides fragilis, an enterotoxin-producing bacterium in the gastrointestinal tract, may be more prevalent in colorectal cancer patients compared to healthy individuals and may induce colon carcinogenesis by activating IL-17 [140]. Here, IL17A is linked to colorectal cancer.